Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
Subscribe To Our Newsletter & Stay Updated